Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK

In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007

(2009) Mark W. Garrison et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004–2007)

(2009) Niels Nørskov-Lauritsen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

BSAC standardized disc susceptibility testing method (version 8)

(2009) J. M. Andrews et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: Results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007

(2008) Michael J. Dowzicky et al.   CLINICAL THERAPEUTICS

Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST)

(2008) Sam K. Bouchillon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

BSAC standardized disc susceptibility testing method (version 7)

(2008) J. M. Andrews et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY